Fonseca and colleagues investigated the impact of C1q, C3, and C5 deficiency in 3xTg-AD mice and found that the contribution of individual complement components to amyloid pathology and neuroinflammation differed in other transgenic models (Tg2576 and Arc48) [250]. This evidence concerns the gene C5 and Alzheimer disease.